| A | B | C | D | E | F | G | H | I | J | K | L | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ||||||||||||
| 2 | Name | Indication | Economics | Admin | Approved | IP | Price | 112 | ||||
| 3 | Skytrokfa (lonapegsomatropin) | pediatric GHD | once-weekly SC | 8/25/2021 | Shares | 55.831561 | ||||||
| 4 | Phase | MC | 6253.134832 | |||||||||
| 5 | PTH | Hypoparathyroidism | 4/30/23 PDUFA | Cash | 935.148 | |||||||
| 6 | CNP | Achondroplasia | Debt | 533.145 | ||||||||
| 7 | TLR7/8 agonist | Oncology | EV | 5851.131831999999 | ||||||||
| 8 | IL-2 beta/gamma | Oncology | ||||||||||
| 9 | ranibizumab | AMD | 2024 IND |